Conditions: Diverticulitis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 592
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine whether SPD476 is effective in reducing recurrence of diverticulitis.

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None arm 4: None

Interventions: intervention 1: SPD476, MMX™ mesalazine, 1.2g extended release tablet intervention 2: SPD476, MMX™ mesalazine, 2.4g extended release tablet intervention 3: SPD476, MMX™ mesalazine, 4.8g extended release tablet intervention 4: Placebo
Intervention descriptions: intervention 1: SPD476 1.2g administered Once Daily (QD) intervention 2: SPD476 2.4g administered Once Daily (QD) intervention 3: SPD476 4.8g administered Once Daily (QD) intervention 4: Placebo administered Once Daily (QD)

Protocol document: